Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02513264 · ClinicalTrials.gov registry record
Registry for Asthma Characterization and Recruitment 2
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 1,384
- Enrollment target
NCT02513264 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,384 participants.
The verdict
NCT02513264 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 1,384 participants
- Enrollment target
Study Summary
There is a need for people to take part in research studies to learn more about diseases and how to treat them. The Registry for Asthma Characterization and Recruitment 2 (RACR2) will create a database of participants with asthma and nasal allergies, or risk factors for these conditions, who are potentially eligible for future Inner City Asthma Consortium (ICAC) trials. The registry database will include assessments of various asthma and allergy characteristics to achieve a more efficient, selective recruitment of these participants for other protocols.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,384 participants |
| Start Date | 2015-04-14 |
| Est. Completion | 2020-03-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02513264
The ClinicalTrials.gov registry entry for NCT02513264 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,384 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02513264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02513264 about?
NCT02513264 is a clinical study titled "Registry for Asthma Characterization and Recruitment 2". There is a need for people to take part in research studies to learn more about diseases and how to treat them. The Registry for Asthma Characterization and Recruitment 2 (RACR2) will create a database of participants with asthma and nasal allergies, or risk factors for these conditions, who are pot...
What is the current status of trial NCT02513264?
This trial is currently completed. The enrollment target is 1,384 participants. The study started on 2015-04-14. Estimated completion is 2020-03-13.
Who is sponsoring clinical trial NCT02513264?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.